Lonza Group AG (LZAGY)
OTC
Real-time Data
01:30 PM
Day's Range
72.8952 wk Range
58.53Overview - LZAGY - Lonza Group AG
Key Statistics
Valuation
Enterprise Value
69.19B
P/E (Trailing)
‪38.07‬
P/E (Forward)
‪26.10‬
PEG Ratio
‪26.10‬
Price / Sales (TTM)
‪7.64‬
Price / Book
‪5.07‬
EV / EBITDA
‪23.11‬
Profitability
Profit Margin
‪-1.60%‬
Operating Margin
‪23.41%‬
Return on Assets
‪5.44%‬
Return on Equity
‪12.89%‬
Ownership
Shares Outstanding
69.84M
Float
697.41M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.03%‬
Price stats
Beta
‪0.83‬
50-Day Avg
‪68.55‬
200-Day Avg
‪66.34‬
Dividends
Payout Ratio
‪32.09%‬
Frequency
Annual
Analyst Consensus
3 analysts
Average price target
‪$ 83.25‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - LZAGY - Lonza Group AG
Peers - LZAGY - Lonza Group AG
Peer Comparison
Compared with companies in Diagnostics & Research listed on OTC.
Profile Summary - LZAGY - Lonza Group AG
About
Lonza Group AG is a Swiss multinational contract development and manufacturing organization (CDMO) serving the pharmaceutical, biotechnology, and nutrition sectors. Headquartered in Basel, Switzerland, and founded in 1897, it specializes in end-to-end solutions from early-phase discovery and custom development to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
